1. Text: | Print|

      MOC decries commercial bribery in wake of GSK case

      2013-07-18 10:08 Global Times Web Editor: qindexing
      1

      The Chinese government is firmly opposed to all types of commercial bribery, a spokesperson for the Ministry of Commerce (MOC) said at a press conference Wednesday following a recent case in which four senior executives of British drug manufacturer GlaxoSmithKline (GSK) were suspected of commercial bribery in China.

      No matter whether an enterprise is domestic or foreign, once it has violated Chinese laws, it must be penalized and take full responsibility, said Ministry of Commerce spokesman Shen Danyang, emphasizing that even a famous multinational corporation such as GSK must obey Chinese laws when doing business in China.

      The Ministry of Public Security recently started an investigation of GSK and found evidence that GSK and related companies may have committed serious crimes of commercial bribery and tax-related violations in China. Further investigation is ongoing, according to Shen.

      GSK published an announcement Monday saying that the company was disappointed with the illegal actions of its staff members and related third-party agencies, and that it will not tolerate such actions.

      Some foreign media have commented that the Chinese government's investigation of GSK indicates that China is becoming aggressive in regulating its investment environment.

      Shen said at the press conference that "the Chinese government has always insisted on its opening-up policies, and will never change its policies about proactively attracting foreign capital."

      China's attitude and actions in the GSK case show that China will continue its efforts to improve its investment environment and create a fair competitive environment for investors around the world, said Shen.

      Following the GSK probe in China, two other well-known global drug manufacturers, Novartis and Roche, which also have large market share in the country, both announced they were not contacted by the Chinese government, Reuters reported Wednesday.

      "We have not been contacted by Chinese authorities on this matter," Novartis Chief Executive Joseph Jimenez was quoted as saying in a Reuters report.

      Roche also said it had not been approached by officials in China.

      "We are not aware of any anti-corruption probes in China against Roche. We are committed to ensure the same high standards of compliance for all Roche employees worldwide," a spokesperson was quoted by Reuters as saying.

      Comments (0)
      Most popular in 24h
        Archived Content
      Media partners:

      Copyright ©1999-2018 Chinanews.com. All rights reserved.
      Reproduction in whole or in part without permission is prohibited.

      主站蜘蛛池模板: 永久在线观看免费视频| 国产亚洲精品看片在线观看| a级特黄毛片免费观看| 中文无码亚洲精品字幕| 亚洲精品国产美女久久久| 成人a视频片在线观看免费| 久9久9精品免费观看| 日韩毛片在线免费观看| 亚洲国产综合人成综合网站00| 亚洲综合日韩久久成人AV| 国产极品美女高潮抽搐免费网站| 99国产精品免费观看视频| 久久不见久久见免费影院www日本| 亚洲偷自拍另类图片二区| 亚洲短视频在线观看| 日韩亚洲人成在线综合日本| 亚洲国产一级在线观看| 日本成人免费在线| 免费高清小黄站在线观看| 国产高清免费视频| 在线成人爽a毛片免费软件| 国产在线播放线91免费| 一级a性色生活片久久无少妇一级婬片免费放 | 哒哒哒免费视频观看在线www| 国产va精品免费观看| 99久久国产免费中文无字幕| 国产啪精品视频网站免费尤物| 一级黄色免费网站| 一级毛片a免费播放王色电影 | 在线播放免费播放av片 | 亚洲a级在线观看| 亚洲天堂一区在线| 久久综合亚洲鲁鲁五月天| 水蜜桃亚洲一二三四在线| 亚洲成AV人片在线观看ww| 亚洲阿v天堂在线| 亚洲国产美国国产综合一区二区| 精品亚洲综合久久中文字幕| 亚洲va在线va天堂va不卡下载| 久久久亚洲欧洲日产国码农村| 亚洲av日韩av无码黑人|